Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, is officially set to showcase its latest advancements in digital orthopaedics at the American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, California.
As a part of this development, the company will introduce cutting-edge implants, advanced techniques, and data-driven technologies across orthopaedic specialties, including joint reconstruction, trauma, extremities, and spine.
Talk about these solutions on a slightly deeper level, we begin from VELYS™ Robotic-Assisted Solution, which arrives on the bearing an ability to help surgeons improve precision, streamline workflows, and at the same time, provide more personalized care.
More on that would reveal how the technology features kinematically designed-and clinically proven ATTUNE™ Knee System that integrates seamlessly with VELYS™ for reducing the risk of revision by almost 33%, as compared to similar total knee replacements.
Recently cleared for unicompartmental knee arthroplasty (UKA) in both medial and lateral procedures, VELYS™ can also facilitate address alignment and precision challenges faced in manual partial knee replacement. This it does by making it possible for surgeons to guide precise implant placement without a CT scan.
Next up, we have the brand-new KINCISE™ 2 Surgical Automated System. As hip and knee procedures require repetitive and forceful motions, Johnson & Johnson MedTech’s latest brainchild delivers automation technology, customizable options, as well as new capabilities like acetabular cup extraction, all of it developed to reduce the physical demands on surgeons during hip or knee procedures.
Another detail worth a mention here is rooted in the company’s VELYS™ Active Robotic Assistance Solution. To understand the significance of such a development, we must take into account how, each year, over 4.83 million spinal surgeries are conducted worldwide, with 1.34 million occurring in the United States alone.
Despite such prevalence of these procedures, first-generation robotic systems can pose significant challenges for surgeons. Against that, Johnson & Johnson MedTech has successfully developed a groundbreaking technology in collaboration with top spine surgeons, a technology specifically aimed at addressing the complexities of advanced spine.
You see, the solution in question can integrate standalone navigation with next-generation active robotic technology to provide flexibility to tailor surgical workflow.
Joining that would be VOLT™ Trauma System Expansion technology. Going by the available details, Johnson & Johnson MedTech’s Variable Angle Optimized Locking Technology (VOLT) can effectively combine dynamic compression with the flexibility of variable angle locking. It does that without compromising stability in any way.
Then, there is INHANCE™ INTACT™ for Shoulder Replacement solution. This technology, recently 510(k) cleared by the FDA, is designed for use with the INHANCE™ Shoulder System in subscapularis-sparing (SCS) total anatomic shoulder replacements.
Thanks to that, patients can move their shoulder without restrictions from the first day post-operatively in subscapularis-sparing approach, as compared to 6 weeks of immobilization with the traditional approach. Not just that, when combined with TRUMATCH™ 3D pre-surgical planning cloud system, surgeons can also tailor SCS procedures to each patient’s unique anatomy for a more personalized approach.
Hold on, we still have a few bits left to unpack, considering we haven’t yet touched upon the new Advance Case Management capacity, which is a digitally integrated solution that simplifies pre-surgery processes for ambulatory surgery centers (ASCs) and outpatient centers by utilizing case schedules and patient data. This translates to greater operating room efficiency through reduced turnover times, smaller inventory footprints, lower sterilization costs, and a better patient experience.
“With over 1.7 billion people worldwide living with musculoskeletal conditions—more than cancer, heart, and lung diseases combined—the need for effective, scalable orthopaedic solutions has never been greater. At AAOS 2025, we are excited to showcase how our innovations are transforming the full ecosystem of orthopaedic procedures to meet this growing demand,” said Aldo Denti, Company Group Chairman of Orthopaedics at Johnson & Johnson MedTech. “By seamlessly integrating innovative implants, advanced surgical techniques, and data-driven enabling technologies, we’re helping surgeons advance patient care while improving efficiency for hospitals and ambulatory surgery centers.”
